{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:34Z","timestamp":1786988074531,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["2023QYJC032"],"award-info":[{"award-number":["2023QYJC032"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JJ5418"],"award-info":[{"award-number":["2024JJ5418"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22177137"],"award-info":[{"award-number":["22177137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271907"],"award-info":[{"award-number":["82271907"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118329","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T21:18:23Z","timestamp":1762463903000},"page":"118329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P2","title":["Discovery of a novel napabucasin derivative B16 as a potent STAT3 inhibitor for the treatment of triple-negative breast cancer"],"prefix":"10.1016","volume":"302","author":[{"given":"Xu","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtai","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyun","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2390-5033","authenticated-orcid":false,"given":"Dayou","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118329_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.semcancer.2020.06.005","article-title":"Pathology of triple negative breast cancer","volume":"72","author":"Borri","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118329_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9080876","article-title":"TNBC: potential targeting of multiple receptors for a therapeutic breakthrough, nanomedicine, and immunotherapy","volume":"9","author":"Singh","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118329_bib3","article-title":"DNA damage response inhibitors: an avenue for TNBC treatment","volume":"1875","author":"Jin","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118329_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118329_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","article-title":"Advances in immunotherapy for triple-negative breast cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118329_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13045-023-01497-3","article-title":"Recent advances in targeted strategies for triple-negative breast cancer","volume":"16","author":"Zhu","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"Pt 3","key":"10.1016\/j.ejmech.2025.118329_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.semcancer.2022.08.003","article-title":"STAT family of transcription factors in breast cancer: pathogenesis and therapeutic opportunities and challenges","volume":"86","author":"Wong","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118329_bib8","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1111\/jcmm.17228","article-title":"JAK-STAT core cancer pathway: an integrative cancer interactome analysis","volume":"26","author":"Erdogan","year":"2022","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118329_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41568-022-00537-3","article-title":"STAT proteins in cancer: orchestration of metabolism","volume":"23","author":"Li","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118329_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12964-020-0527-z","article-title":"Role of STAT3 signaling pathway in breast cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Cell Commun. Signal."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118329_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-22-0423","article-title":"JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states","volume":"83","author":"Stevens","year":"2023","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.ejmech.2025.118329_bib12","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2174\/0113895575254012231024062619","article-title":"Targeting STAT3 enzyme for cancer treatment","volume":"24","author":"Arun","year":"2024","journal-title":"Mini Rev. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118329_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051107","article-title":"STAT3: versatile functions in non-small cell lung cancer","volume":"12","author":"Mohrherr","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118329_bib14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.gendis.2021.04.003","article-title":"Targeting LIF\/LIFR signaling in cancer","volume":"9","author":"Viswanadhapalli","year":"2022","journal-title":"Genes & diseases"},{"issue":"18","key":"10.1016\/j.ejmech.2025.118329_bib15","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1182\/blood.2023021790","article-title":"A modern view of LGL leukemia","volume":"144","author":"Marchand","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118329_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12943-023-01929-1","article-title":"JAK\/STAT in leukemia: a clinical update","volume":"23","author":"Liang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118329_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J Exp Clin Canc Res"},{"key":"10.1016\/j.ejmech.2025.118329_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120996","article-title":"Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors","volume":"309","author":"Dinakar","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118329_bib19","first-page":"157","article-title":"Nuclear expression of p-STAT3 is associated with poor prognosis in ER(-) breast cancer. Clin","volume":"12","author":"Nakagawa","year":"2022","journal-title":"Pract"},{"issue":"9","key":"10.1016\/j.ejmech.2025.118329_bib20","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1007\/s00210-024-03095-7","article-title":"Arnicolide D: a multi-targeted anticancer sesquiterpene lactone-preclinical efficacy and mechanistic insights","volume":"397","author":"Mangalpady","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118329_bib21","article-title":"Clinicopathological and prognostic role of STAT3\/p-STAT3 in breast cancer patients in China: a meta-analysis","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118329_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118329_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12974","article-title":"STAT3 and its targeting inhibitors in osteosarcoma","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118329_bib24","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"13","key":"10.1016\/j.ejmech.2025.118329_bib25","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1021\/acs.jmedchem.1c00629","article-title":"Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation","volume":"64","author":"Dong","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118329_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111922","article-title":"Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: where are we and where should we go?","volume":"187","author":"Huang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118329_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300526","article-title":"Design, synthesis, and biological evaluation of naphthoylamide derivatives as inhibitors of STAT3 phosphorylation","volume":"357","author":"Lu","year":"2024","journal-title":"Arch. Pharm."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118329_bib28","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1073\/pnas.1424171112","article-title":"Suppression of cancer relapse and metastasis by inhibiting cancer stemness","volume":"112","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118329_bib29","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"A small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem Biol"},{"issue":"18","key":"10.1016\/j.ejmech.2025.118329_bib30","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1073\/pnas.0609757104","article-title":"Selective chemical probe inhibitor of STAT3, identified through structure-based virtual screening, induces antitumor activity","volume":"104","author":"Siddiquee","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"13","key":"10.1016\/j.ejmech.2025.118329_bib31","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1073\/pnas.0409894102","article-title":"A low-molecular-weight compound discovered through virtual database screening inhibits STAT3 function in breast cancer cells","volume":"102","author":"Song","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2025.118329_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114688","article-title":"TTI-101: a competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic pain","volume":"192","author":"Kasembeli","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118329_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1021\/ml1000273","article-title":"Identification of a new series of STAT3 inhibitors by virtual screening","volume":"1","author":"Matsuno","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118329_bib34","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12906-022-03727-6","article-title":"Novel mechanism of napabucasin, a naturally derived furanonaphthoquinone: apoptosis and autophagy induction in lung cancer cells through direct targeting on Akt\/mTOR proteins","volume":"22","author":"Petsri","year":"2022","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.ejmech.2025.118329_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108118","article-title":"The role of the STAT3 signaling transduction pathways in radioresistance","volume":"234","author":"Shih","year":"2022","journal-title":"Pharmacol. Therapeut."},{"issue":"15","key":"10.1016\/j.ejmech.2025.118329_bib36","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.3390\/molecules28155678","article-title":"The anticancer effect of napabucasin (BBI608), a natural naphthoquinone","volume":"28","author":"Shao","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118329_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2018.03.054","article-title":"Design, synthesis and activity of BBI608 derivatives targeting on stem cells","volume":"151","author":"Zhou","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118329_bib38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejmech.2018.10.067","article-title":"A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3)","volume":"162","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2025.118329_bib39","doi-asserted-by":"crossref","first-page":"15291","DOI":"10.1021\/acs.jmedchem.4c00872","article-title":"Natural product-inspired discovery of naphthoquinone-furo-piperidine derivatives as novel STAT3 inhibitors for the treatment of triple-negative breast cancer","volume":"67","author":"Fan","year":"2024","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118329_bib40","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1021\/acs.jmedchem.0c01897","article-title":"Discovery of a napabucasin PROTAC as an effective degrader of the E3 ligase ZFP91","volume":"64","author":"Hanafi","year":"2021","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2025.118329_bib41","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1021\/jm3009597","volume":"55","author":"Reichstein","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118329_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107617","article-title":"Synthesis and biological evaluation of novel isoxazoloquinone derivatives as potent STAT3-targeting antipsoriasis agents","volume":"151","author":"Chen","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2025.118329_bib43","doi-asserted-by":"crossref","first-page":"15438","DOI":"10.1021\/acs.jmedchem.4c01055","article-title":"Design, synthesis, and biological activity of novel quinone derivatives as potent STAT3 inhibitors for psoriasis treatment","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118329_bib44","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ejmech.2017.10.043","article-title":"Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors","volume":"143","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2025.118329_bib45","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118329_bib46","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner","year":"1999","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2025.118329_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J Cheminform"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118329_bib48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13321-018-0285-8","article-title":"P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure","volume":"10","author":"Kriv\u00e1k","year":"2018","journal-title":"J Cheminform"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118329_bib49","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"W1","key":"10.1016\/j.ejmech.2025.118329_bib50","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:02:44Z","timestamp":1780909364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425010943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"alternative-id":["S0223523425010943"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118329","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel napabucasin derivative B16 as a potent STAT3 inhibitor for the treatment of triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118329"}}